A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Lotte Biologics Co., the biotech arm of Lotte Group, said Thursday it has signed a deal with an Asia-based biotech company ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special purpose acquisition company (SPAC) model to hop onto the Nasdaq. | Market ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire therapeutic landscape and the whole drug discovery pipeline.

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

BigHat Biosciences, a biotechnology company, has entered a strategic collaboration with Eli Lilly and Company.